article thumbnail

Fear of another heart attack may be a major source of ongoing stress for survivors

Science Daily - Heart Disease

Fear of another heart attack was a significant ongoing contributor to how heart attack survivors perceive their health, according to a study. While anxiety and depression are recognized as common conditions after a heart attack, they did not explain the impact of fear of recurrence in this study.

article thumbnail

Signatures of heart attack

Science Daily - Heart Disease

Researchers have mapped the immune response in heart attacks and identified signatures that correlate with the clinical progression.

article thumbnail

Researchers identify 'sweet spot' for safe surgery after heart attack

Science Daily - Heart Disease

New research suggests older adults wait 3-6 months after a heart attack before elective noncardiac surgery to reduce the risk of serious complications like stroke or another heart attack.

article thumbnail

Cannabis users face substantially higher risk of heart attack

Science Daily - Heart Disease

Two new studies add to mounting evidence that people who use cannabis are more likely to suffer a heart attack than people who do not use the drug, even among younger and otherwise healthy adults. Marijuana is now legal in many places, but is it safe? The findings are from a retrospective study of over 4.6

article thumbnail

Is long-term beta-blocker therapy needed after a heart attack?

Science Daily - Heart Disease

The appropriate duration of beta-blocker treatment after a heart attack (a myocardial infarction [MI]) is unknown in patients who do not need to take beta-blockers for another reason.

article thumbnail

Unnecessary use of beta-blockers after a heart attack?

Science Daily - Heart Disease

Half of all patients discharged from hospital after a heart attack are treated with beta-blockers unnecessarily, new study suggests.

article thumbnail

Experimental drug engineered to prevent heart failure after heart attacks

Science Daily - Heart Disease

An experimental therapeutic monoclonal antibody therapy could become the first to directly enhance tissue repair in the heart following a heart attack.